Skip to main content

Table 2 Cases

From: Double-labelling immunohistochemistry for MGMT and a “cocktail” of non-tumourous elements is a reliable, quick and easy technique for inferring methylation status in glioblastomas and other primary brain tumours

case ID

type

LI

SL

MLPA

MLPA 0-3

MLPA >0.25

DL

1

oligo

7.567

1

0.6275

2

1

1

2

oligo

13.700

1

0.675

2

1

1

3

oligo

12.600

1

0.8075

3

1

1

4

oligo

24.667

1

0.4725

1

1

1

5

oligo

17.100

1

0.8525

3

1

1

6

oligo

13.600

1

0.8025

3

1

1

7

oligo

19.567

1

0.6425

2

1

1

8

oligo

14.267

1

0.6925

2

1

1

9

oligo

8.800

1

0.6525

2

1

1

10

oligo

26.133

1

0.5925

2

1

*1

11

gbm

56.367

0

0.1125

0

0

0

12

gbm

19.167

1

0.8475

3

1

1

13

gbm

84.400

0

0.09

0

0

0

14

gbm

17.967

1

0.2625

1

1

*1

15

gbm

57.700

0

0.255

1

1

0

16

gbm

89.900

0

0.4075

1

1

0

17

gbm

72.267

0

0.2075

0

0

0

18

gbm

19.533

1

0.3525

1

1

*1

19

gbm

54.133

0

0.42

1

1

*1

20

gbm

53.900

0

0.1375

0

0

0

21

gbm

21.967

1

0.485

1

1

1

22

gbm

54.167

0

0.5475

2

1

1

23

gbm

33.000

1

0.085

0

0

0

24

gbm

76.300

0

0.2725

1

1

0

25

gbm

96.733

0

0.24

0

0

0

26

gbm

49.567

1

0.4275

1

1

1

27

gbm

43.967

1

0.1375

0

0

*1

28

gbm

40.533

1

0.1025

0

0

0

29

gbm

7.233

1

0.1275

0

0

1

30

gbm

39.067

1

0.5125

2

1

1

31

gbm

25.833

1

0.2075

0

0

*1

32

gbm

33.900

1

0.13

0

0

*1

33

gbm

28.000

1

0.365

1

1

0

34

gbm

45.000

1

0.275

1

1

1

35

gbm

84.100

0

0.205

0

0

0

36

gbm

85.100

0

0.2975

1

1

0

37

gbm

64.933

0

0.11

0

0

0

38

gbm

53.400

0

0.17

0

0

0

39

gbm

6.800

1

0.825

3

1

1

40

gbm

22.500

1

0.2425

0

0

0

  1. Case ID (identification) is the case number we assigned in this study. Tumour types were oligodendroglial tumours (oligo) and glioblastomas (gbm). The oligodendroglial tumours were oligodendroglioma WHO grade II (cases 4, 5 and 6), anaplastic oligodendroglioma WHO grade III (cases 1, 2, 3, 7 and 9), oligoastrocytoma WHO grade II (case 10) and anaplastic oligoastrocytoma WHO grade III (case 8). The glioblastomas were all glioblastoma WHO grade IV except cases 13 and 18 which were glioblastoma with oligodendroglioma component WHO grade IV. LI is the nuclear labelling index for single-labelled MGMT as determined by computerised image analysis. SL is the binarised score for the single-labelling (0 = LI > 50%, 1 = LI from 0 to 50%). MLPA is the MLPA ratio (please see text). MLPA 0–3 is the score for MLPA according to cut-offs for the MLPA ratio provided by Jeuken et al. 2007 [10] (0 = unmethylated, 1 = mildly methylated, 2 = moderately methylated and 3 = extensively methylated). MLPA > 0.25 is the binarised methylation score for MLPA (0 = unmethylated, 1 =methylated). DL is the binarised score for double labelling (0 = mainly MGMT-positive in tumour cells, 1 = mainly MGMT-negative in tumour cells). The asterisked cases were initially assigned a score of 1 in the tripartite system (please see text for explanation).